Overview

The Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones Fractures

Status:
Unknown status
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This randomized, placebo-controlled study will evaluate the effectiveness of the adjunctive use of teriparatide for the healing of Jones fractures.
Phase:
Phase 4
Details
Lead Sponsor:
Ohio Orthopedic Center of Excellence
Collaborator:
Eli Lilly and Company
Treatments:
Teriparatide